Escherichia Coli Rho GTPase-activating Toxin CNF1 Mediates NLRP3 Inflammasome Activation Via P21-activated Kinases-1/2 During Bacteraemia in Mice

Overview

Journal Nat Microbiol

Specialties Microbiology
Parasitology

Date 2021 Jan 12

PMID 33432150

Citations 37

Authors

Oceane Dufies

Anne Doye

Johan Courjon

Cedric Torre

Gregory Michel

Celine Loubatier

Arnaud Jacquel

Paul Chaintreuil

Alissa Majoor

Rodolphe R Guinamard

Alexandre Gallerand

Pedro H V Saavedra

Els Verhoeyen

Amaury Rey

Sandrine Marchetti

Raymond Ruimy

Dorota Czerucka

Mohamed Lamkanfi

Benedicte F Py

Patrick Munro

Orane Visvikis

Laurent Boyer

Affiliations

Soon will be listed here.

Abstract

Inflammasomes are signalling platforms that are assembled in response to infection or sterile inflammation by cytosolic pattern recognition receptors. The consequent inflammasome-triggered caspase-1 activation is critical for the host defence against pathogens. During infection, NLRP3, which is a pattern recognition receptor that is also known as cryopyrin, triggers the assembly of the inflammasome-activating caspase-1 through the recruitment of ASC and Nek7. The activation of the NLRP3 inflammasome is tightly controlled both transcriptionally and post-translationally. Despite the importance of the NLRP3 inflammasome regulation in autoinflammatory and infectious diseases, little is known about the mechanism controlling the activation of NLRP3 and the upstream signalling that regulates the NLRP3 inflammasome assembly. We have previously shown that the Rho-GTPase-activating toxin from Escherichia coli cytotoxic necrotizing factor-1 (CNF1) activates caspase-1, but the upstream mechanism is unclear. Here, we provide evidence of the role of the NLRP3 inflammasome in sensing the activity of bacterial toxins and virulence factors that activate host Rho GTPases. We demonstrate that this activation relies on the monitoring of the toxin's activity on the Rho GTPase Rac2. We also show that the NLRP3 inflammasome is activated by a signalling cascade that involves the p21-activated kinases 1 and 2 (Pak1/2) and the Pak1-mediated phosphorylation of Thr 659 of NLRP3, which is necessary for the NLRP3-Nek7 interaction, inflammasome activation and IL-1β cytokine maturation. Furthermore, inhibition of the Pak-NLRP3 axis decreases the bacterial clearance of CNF1-expressing UTI89 E. coli during bacteraemia in mice. Taken together, our results establish that Pak1 and Pak2 are critical regulators of the NLRP3 inflammasome and reveal the role of the Pak-NLRP3 signalling axis in vivo during bacteraemia in mice.

Citing Articles

Guards and decoys: RIPoptosome and inflammasome pathway regulators of bacterial effector-triggered immunity.

Malik H, Bliska J PLoS Pathog. 2025; 21(1):e1012884.

PMID: 39883598 PMC: 11781737. DOI: 10.1371/journal.ppat.1012884.

enhances dextran sulfate sodium-induced colitis by promoting nf-κB-NLRP3-Dependent macrophage pyroptosis.

Shen X, Guan J, Lu D, Hong S, Yu L, Chen X Virulence. 2024; 15(1):2435391.

PMID: 39611567 PMC: 11610558. DOI: 10.1080/21505594.2024.2435391.

The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets.

Zhou Y, Dang J, Yang Q, Sun Z EBioMedicine. 2024; 109:105420.

PMID: 39476537 PMC: 11564932. DOI: 10.1016/j.ebiom.2024.105420.

Combined bacterial translocation and cholestasis aggravates liver injury by activation pyroptosis in obstructive jaundice.

Shen X, Zhang X, Li K, Huang G, Li X, Hou Y Heliyon. 2024; 10(16):e35793.

PMID: 39220957 PMC: 11363856. DOI: 10.1016/j.heliyon.2024.e35793.

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation.

Doye A, Chaintreuil P, Lagresle-Peyrou C, Batistic L, Marion V, Munro P J Exp Med. 2024; 221(10).

PMID: 39212656 PMC: 11363864. DOI: 10.1084/jem.20231562.

References

Martin G, Mannino D, Eaton S, Moss M . The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348(16):1546-54. DOI: 10.1056/NEJMoa022139. View

Vance R, Isberg R, Portnoy D . Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe. 2009; 6(1):10-21. PMC: 2777727. DOI: 10.1016/j.chom.2009.06.007. View

Stuart L, Paquette N, Boyer L . Effector-triggered versus pattern-triggered immunity: how animals sense pathogens. Nat Rev Immunol. 2013; 13(3):199-206. PMC: 4121468. DOI: 10.1038/nri3398. View

Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C . Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 1997; 387(6634):729-33. DOI: 10.1038/42743. View

Schmidt G, Sehr P, Wilm M, SELZER J, Mann M, Aktories K . Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 1997; 387(6634):725-9. DOI: 10.1038/42735. View

Aktories K, Barbieri J . Bacterial cytotoxins: targeting eukaryotic switches. Nat Rev Microbiol. 2005; 3(5):397-410. DOI: 10.1038/nrmicro1150. View

Galan J . Common themes in the design and function of bacterial effectors. Cell Host Microbe. 2009; 5(6):571-9. PMC: 2729653. DOI: 10.1016/j.chom.2009.04.008. View

Bruno V, Hannemann S, Lara-Tejero M, Flavell R, Kleinstein S, Galan J . Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog. 2009; 5(8):e1000538. PMC: 2714975. DOI: 10.1371/journal.ppat.1000538. View

Munro P, Flatau G, Doye A, Boyer L, Oregioni O, Mege J . Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem. 2004; 279(34):35849-57. DOI: 10.1074/jbc.M401580200. View

10.

Boquet P, Lemichez E . Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis?. Trends Cell Biol. 2003; 13(5):238-46. DOI: 10.1016/s0962-8924(03)00037-0. View

11.

Diabate M, Munro P, Garcia E, Jacquel A, Michel G, Obba S . Escherichia coli α-hemolysin counteracts the anti-virulence innate immune response triggered by the Rho GTPase activating toxin CNF1 during bacteremia. PLoS Pathog. 2015; 11(3):e1004732. PMC: 4363529. DOI: 10.1371/journal.ppat.1004732. View

12.

Xu H, Yang J, Gao W, Li L, Li P, Zhang L . Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014; 513(7517):237-41. DOI: 10.1038/nature13449. View

13.

Groslambert M, Py B . Spotlight on the NLRP3 inflammasome pathway. J Inflamm Res. 2018; 11:359-374. PMC: 6161739. DOI: 10.2147/JIR.S141220. View

14.

Yang Y, Wang H, Kouadir M, Song H, Shi F . Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019; 10(2):128. PMC: 6372664. DOI: 10.1038/s41419-019-1413-8. View

15.

Gao W, Yang J, Liu W, Wang Y, Shao F . Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A. 2016; 113(33):E4857-66. PMC: 4995971. DOI: 10.1073/pnas.1601700113. View

16.

Park Y, Wood G, Kastner D, Chae J . Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016; 17(8):914-21. PMC: 4955684. DOI: 10.1038/ni.3457. View

17.

Tzeng T, Schattgen S, Monks B, Wang D, Cerny A, Latz E . A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection. Cell Rep. 2016; 16(2):571-582. PMC: 5384574. DOI: 10.1016/j.celrep.2016.06.011. View

18.

Lamkanfi M, Dixit V . In Retrospect: The inflammasome turns 15. Nature. 2017; 548(7669):534-535. DOI: 10.1038/548534a. View

19.

He Y, Hara H, Nunez G . Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016; 41(12):1012-1021. PMC: 5123939. DOI: 10.1016/j.tibs.2016.09.002. View

20.

Shi H, Murray A, Beutler B . Reconstruction of the Mouse Inflammasome System in HEK293T Cells. Bio Protoc. 2017; 6(21). PMC: 5431583. DOI: 10.21769/BioProtoc.1986. View